110 related articles for article (PubMed ID: 6230712)
1. p69,71 antigen complex detected by monoclonal antibody Leu 1 in the identification of particular stages of malignant B-cell differentiation.
Herrmann F; Komischke B; Langermann HJ; Ludwig WD; Sieber G; Rühl H
Scand J Haematol; 1984 Feb; 32(2):215-22. PubMed ID: 6230712
[TBL] [Abstract][Full Text] [Related]
2. Characterization of B-cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody.
Koziner B; Gebhard D; Denny T; Evans RL
Am J Med; 1982 Dec; 73(6):802-7. PubMed ID: 6756136
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.
Knowles DM; Halper JP; Azzo W; Wang CY
Cancer; 1983 Oct; 52(8):1369-77. PubMed ID: 6193856
[TBL] [Abstract][Full Text] [Related]
4. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
5. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.
Pulford K; Ralfkiaer E; MacDonald SM; Erber WN; Falini B; Gatter KC; Mason DY
Immunology; 1986 Jan; 57(1):71-6. PubMed ID: 3484721
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
8. Relationship between different cell surface markers in chronic lymphocytic leukemia.
Potomski J; Harłozińska A; Becker M; Noworolska A
Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
Zipf TF; Lauzon GJ; Longenecker BM
J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
[TBL] [Abstract][Full Text] [Related]
10. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
Iida K; Nadler L; Nussenzweig V
J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
[TBL] [Abstract][Full Text] [Related]
11. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
Melo JV; Catovsky D; Bodger M
Scand J Haematol; 1984 Apr; 32(4):417-22. PubMed ID: 6609424
[TBL] [Abstract][Full Text] [Related]
14. Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.
Greil R; Gattringer C; Schulz T; Knapp W; Radaskiewicz T; Dierich MP; Huber H
Clin Exp Immunol; 1986 May; 64(2):423-31. PubMed ID: 2943542
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
16. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
17. Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies.
Koziner B; Gebhard D; Denny T; McKenzie S; Clarkson BD; Miller DA; Evans RL
Blood; 1982 Sep; 60(3):752-7. PubMed ID: 6809078
[TBL] [Abstract][Full Text] [Related]
18. Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells.
Wang CY; Good RA; Ammirati P; Dymbort G; Evans RL
J Exp Med; 1980 Jun; 151(6):1539-44. PubMed ID: 6155425
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]